Ondansetron and Arterial thrombosis limb - a phase IV clinical study of FDA data

Summary:

Arterial thrombosis limb is found among people who take Ondansetron, especially for people who are female, 30-39 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ondansetron and have Arterial thrombosis limb. It is created by eHealthMe based on reports of 97,041 people who have side effects when taking Ondansetron from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 03, 2023

97,041 people reported to have side effects when taking Ondansetron.
Among them, 15 people (0.02%) have Arterial thrombosis limb.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 97,518 Ondansetron users for its effectiveness, alternative drugs and more.

What is Arterial thrombosis limb?

Arterial thrombosis limb (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system-limb) is found to be associated with 603 drugs and 321 conditions by eHealthMe.

Number of Ondansetron and Arterial thrombosis limb reports submitted per year:

Could Ondansetron cause Arterial thrombosis limb?

Time on Ondansetron when people have Arterial thrombosis limb *:

Gender of people who have Arterial thrombosis limb when taking Ondansetron *:

female: 66.67 %
male: 33.33 %

Age of people who have Arterial thrombosis limb when taking Ondansetron *:

Common drugs people take besides Ondansetron *:

Common side effects people have besides Arterial thrombosis limb *:

Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 20.00%
Pain: 3 people, 20.00%
Pulse Absent: 2 people, 13.33%
Peripheral Occlusive Disease (narrowing of blood vessels that restricts blood flow): 2 people, 13.33%
Peripheral Ischaemia (impaired circulation to an extremity): 2 people, 13.33%
Emotional Distress: 2 people, 13.33%
Foot Amputation (loss of foot): 2 people, 13.33%
Vascular Occlusion (sudden blockage of a blood vessel, usually with a clot): 1 person, 6.67%
Gallbladder Injury: 1 person, 6.67%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 6.67%

Common conditions people have *:

High Blood Pressure: 2 people, 13.33%
Colon Cancer: 2 people, 13.33%
Birth Control: 2 people, 13.33%
Acne (skin problems that cause pimples): 2 people, 13.33%
Testis Cancer (testes cancer): 1 person, 6.67%
Premenstrual Syndrome: 1 person, 6.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 6.67%
Gastric Cancer (stomach cancer): 1 person, 6.67%
Diabetes: 1 person, 6.67%
Chest Pain: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ondansetron and have Arterial thrombosis limb?

Check whether Arterial thrombosis limb is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Arterial thrombosis limb and when was it recovered:

Arterial thrombosis limb in Ondansetron

Expand to all the drugs that have ingredients of ondansetron:

Arterial thrombosis limb and drugs with ingredients of ondansetron

Alternative drugs to, pros and cons of Ondansetron:

Ondansetron (97,518 reports)

Common Ondansetron side effects:

Fatigue (feeling of tiredness): 7,906 reports
Diarrhea: 7,566 reports
Indigestion: 7,466 reports
Nausea and vomiting: 5,892 reports
Breathing difficulty: 4,948 reports
Fever: 4,852 reports
Pain: 4,481 reports
Weakness: 4,224 reports

Browse all side effects of Ondansetron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Arterial thrombosis limb treatments and more:

Arterial thrombosis limb (1,010 reports)

COVID vaccines that are related to Arterial thrombosis limb:

All the drugs that are associated with Arterial thrombosis limb:

Arterial thrombosis limb (603 drugs)

All the conditions that are associated with Arterial thrombosis limb:

Arterial thrombosis limb (321 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ondansetron (the active ingredients of Ondansetron) and Ondansetron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.